GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CVRX · Jun 30, 2026

CVRx, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001628280-26-054336General Corporate
Capex intensity17thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.71% · OPTIONAL · VALID

Operating cash generation100thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-56.20% · OPTIONAL · VALID

Revenue growth50thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

15.57% · CORE · VALID

Inventory pressure33thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

82.95% · OPTIONAL · VALID

Gross margin100thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.gross_margin

87.39% · CORE · VALID

Operating margin92thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.operating_margin

-82.92% · CORE · VALID

R&D intensity25thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

19.93% · OPTIONAL · VALID

SBC intensity83thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

23.32% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesHistory building
Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
0.83%
Current
0.71%
Delta
-0.11%
Cash Generation Increased
Previous
-82.36%
Current
-56.20%
Delta
26.16%
Growth Decreased
Previous
19.61%
Current
15.57%
Delta
-4.04%
Inventory Pressure Decreased
Previous
83.98%
Current
82.95%
Delta
-1.03%
Margin Increased
Previous
87.22%
Current
87.39%
Delta
0.17%
Profitability Decreased
Previous
-82.34%
Current
-82.92%
Delta
-0.58%
R And D Intensity Decreased
Previous
20.88%
Current
19.93%
Delta
-0.95%
Sbc Intensity Increased
Previous
19.74%
Current
23.32%
Delta
3.58%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Compared To · Surgical & Medical Instruments & Apparatus peers →Derived From · CVRX Company Quality Vector →Has State · CVRx, Inc. →Transitioned To · CVRX Fundamental State →Transitioned To · CVRX CAPEX_INTENSITY_DECREASED →Transitioned To · CVRX CASH_GENERATION_INCREASED →Transitioned To · CVRX GROWTH_DECREASED →Transitioned To · CVRX INVENTORY_PRESSURE_DECREASED →Transitioned To · CVRX MARGIN_INCREASED →Transitioned To · CVRX PROFITABILITY_DECREASED →Transitioned To · CVRX R_AND_D_INTENSITY_DECREASED →Transitioned To · CVRX SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.